1 Introduction to Research & Analysis Reports
1.1 BCG and Tuberculosis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global BCG and Tuberculosis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global BCG and Tuberculosis Vaccine Overall Market Size
2.1 Global BCG and Tuberculosis Vaccine Market Size: 2022 VS 2029
2.2 Global BCG and Tuberculosis Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global BCG and Tuberculosis Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top BCG and Tuberculosis Vaccine Players in Global Market
3.2 Top Global BCG and Tuberculosis Vaccine Companies Ranked by Revenue
3.3 Global BCG and Tuberculosis Vaccine Revenue by Companies
3.4 Global BCG and Tuberculosis Vaccine Sales by Companies
3.5 Global BCG and Tuberculosis Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 BCG and Tuberculosis Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers BCG and Tuberculosis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 BCG and Tuberculosis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 BCG and Tuberculosis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 BCG and Tuberculosis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global BCG and Tuberculosis Vaccine Market Size Markets, 2022 & 2029
4.1.2 Immune Vaccine
4.1.3 Therapy Vaccine
4.2 By Type – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
4.2.1 By Type – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
4.2.2 By Type – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
4.2.3 By Type – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global BCG and Tuberculosis Vaccine Sales & Forecasts
4.3.1 By Type – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
4.3.2 By Type – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
4.3.3 By Type – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global BCG and Tuberculosis Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global BCG and Tuberculosis Vaccine Market Size, 2022 & 2029
5.1.2 Self-Procurement
5.1.3 UNICEF
5.1.4 Others
5.2 By Application – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
5.2.1 By Application – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
5.2.2 By Application – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
5.2.3 By Application – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global BCG and Tuberculosis Vaccine Sales & Forecasts
5.3.1 By Application – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
5.3.2 By Application – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
5.3.3 By Application – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global BCG and Tuberculosis Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global BCG and Tuberculosis Vaccine Market Size, 2022 & 2029
6.2 By Region – Global BCG and Tuberculosis Vaccine Revenue & Forecasts
6.2.1 By Region – Global BCG and Tuberculosis Vaccine Revenue, 2018-2023
6.2.2 By Region – Global BCG and Tuberculosis Vaccine Revenue, 2024-2029
6.2.3 By Region – Global BCG and Tuberculosis Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global BCG and Tuberculosis Vaccine Sales & Forecasts
6.3.1 By Region – Global BCG and Tuberculosis Vaccine Sales, 2018-2023
6.3.2 By Region – Global BCG and Tuberculosis Vaccine Sales, 2024-2029
6.3.3 By Region – Global BCG and Tuberculosis Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.4.2 By Country – North America BCG and Tuberculosis Vaccine Sales, 2018-2029
6.4.3 US BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.4.4 Canada BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.4.5 Mexico BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe BCG and Tuberculosis Vaccine Sales, 2018-2029
6.5.3 Germany BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.4 France BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.5 U.K. BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.6 Italy BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.7 Russia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.5.9 Benelux BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia BCG and Tuberculosis Vaccine Sales, 2018-2029
6.6.3 China BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.4 Japan BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.5 South Korea BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.6.7 India BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.7.2 By Country – South America BCG and Tuberculosis Vaccine Sales, 2018-2029
6.7.3 Brazil BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.7.4 Argentina BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa BCG and Tuberculosis Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa BCG and Tuberculosis Vaccine Sales, 2018-2029
6.8.3 Turkey BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.4 Israel BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia BCG and Tuberculosis Vaccine Market Size, 2018-2029
6.8.6 UAE BCG and Tuberculosis Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck BCG and Tuberculosis Vaccine Major Product Offerings
7.1.4 Merck BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Japan BCG Lab
7.2.1 Japan BCG Lab Company Summary
7.2.2 Japan BCG Lab Business Overview
7.2.3 Japan BCG Lab BCG and Tuberculosis Vaccine Major Product Offerings
7.2.4 Japan BCG Lab BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Japan BCG Lab Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India BCG and Tuberculosis Vaccine Major Product Offerings
7.3.4 Serum Institute of India BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 AJ Vaccines
7.4.1 AJ Vaccines Company Summary
7.4.2 AJ Vaccines Business Overview
7.4.3 AJ Vaccines BCG and Tuberculosis Vaccine Major Product Offerings
7.4.4 AJ Vaccines BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 AJ Vaccines Key News & Latest Developments
7.5 BioFarma
7.5.1 BioFarma Company Summary
7.5.2 BioFarma Business Overview
7.5.3 BioFarma BCG and Tuberculosis Vaccine Major Product Offerings
7.5.4 BioFarma BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 BioFarma Key News & Latest Developments
7.6 GreenSignal Bio Pharma
7.6.1 GreenSignal Bio Pharma Company Summary
7.6.2 GreenSignal Bio Pharma Business Overview
7.6.3 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Major Product Offerings
7.6.4 GreenSignal Bio Pharma BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 GreenSignal Bio Pharma Key News & Latest Developments
7.7 China National Biotec
7.7.1 China National Biotec Company Summary
7.7.2 China National Biotec Business Overview
7.7.3 China National Biotec BCG and Tuberculosis Vaccine Major Product Offerings
7.7.4 China National Biotec BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 China National Biotec Key News & Latest Developments
7.8 Biomed Lublin
7.8.1 Biomed Lublin Company Summary
7.8.2 Biomed Lublin Business Overview
7.8.3 Biomed Lublin BCG and Tuberculosis Vaccine Major Product Offerings
7.8.4 Biomed Lublin BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Biomed Lublin Key News & Latest Developments
7.9 Taj Pharmaceuticals
7.9.1 Taj Pharmaceuticals Company Summary
7.9.2 Taj Pharmaceuticals Business Overview
7.9.3 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Major Product Offerings
7.9.4 Taj Pharmaceuticals BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Taj Pharmaceuticals Key News & Latest Developments
7.10 Ataulpho de Paiva
7.10.1 Ataulpho de Paiva Company Summary
7.10.2 Ataulpho de Paiva Business Overview
7.10.3 Ataulpho de Paiva BCG and Tuberculosis Vaccine Major Product Offerings
7.10.4 Ataulpho de Paiva BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Ataulpho de Paiva Key News & Latest Developments
7.11 IVAC-Institute of Vaccines and Medical Biologicals
7.11.1 IVAC-Institute of Vaccines and Medical Biologicals Company Summary
7.11.2 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Business Overview
7.11.3 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Major Product Offerings
7.11.4 IVAC-Institute of Vaccines and Medical Biologicals BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 IVAC-Institute of Vaccines and Medical Biologicals Key News & Latest Developments
7.12 Queen Saovabha Mem. Inst
7.12.1 Queen Saovabha Mem. Inst Company Summary
7.12.2 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Business Overview
7.12.3 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Major Product Offerings
7.12.4 Queen Saovabha Mem. Inst BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Queen Saovabha Mem. Inst Key News & Latest Developments
7.13 Microgen
7.13.1 Microgen Company Summary
7.13.2 Microgen BCG and Tuberculosis Vaccine Business Overview
7.13.3 Microgen BCG and Tuberculosis Vaccine Major Product Offerings
7.13.4 Microgen BCG and Tuberculosis Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Microgen Key News & Latest Developments
8 Global BCG and Tuberculosis Vaccine Production Capacity, Analysis
8.1 Global BCG and Tuberculosis Vaccine Production Capacity, 2018-2029
8.2 BCG and Tuberculosis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global BCG and Tuberculosis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 BCG and Tuberculosis Vaccine Supply Chain Analysis
10.1 BCG and Tuberculosis Vaccine Industry Value Chain
10.2 BCG and Tuberculosis Vaccine Upstream Market
10.3 BCG and Tuberculosis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 BCG and Tuberculosis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のBCG&結核ワクチン市場予測2023-2029：免疫ワクチン、治療ワクチン |
| 【英語タイトル】BCG and Tuberculosis Vaccine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5707 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：78 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のBCG&結核ワクチン市場規模と予測を収録しています。・世界のBCG&結核ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のBCG&結核ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のBCG&結核ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫ワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 BCG&結核ワクチンのグローバル主要企業は、Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、BCG&結核ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のBCG&結核ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のBCG&結核ワクチン市場：タイプ別市場シェア、2022年 ・免疫ワクチン、治療ワクチン 世界のBCG&結核ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のBCG&結核ワクチン市場：用途別市場シェア、2022年 ・自主調達、ユニセフ、その他 世界のBCG&結核ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のBCG&結核ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるBCG&結核ワクチンのグローバル売上、2018年-2023年 ・主要企業におけるBCG&結核ワクチンのグローバル売上シェア、2022年 ・主要企業におけるBCG&結核ワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるBCG&結核ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgen ************************************************************* ・調査・分析レポートの概要 BCG&結核ワクチン市場の定義 市場セグメント 世界のBCG&結核ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のBCG&結核ワクチン市場規模 世界のBCG&結核ワクチン市場規模：2022年 VS 2029年 世界のBCG&結核ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのBCG&結核ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のBCG&結核ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：免疫ワクチン、治療ワクチン BCG&結核ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：自主調達、ユニセフ、その他 BCG&結核ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別BCG&結核ワクチン市場規模 2022年と2029年 地域別BCG&結核ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Merck、 Japan BCG Lab、 Serum Institute of India、 AJ Vaccines、 BioFarma、 GreenSignal Bio Pharma、 China National Biotec、 Biomed Lublin、 Taj Pharmaceuticals、 Ataulpho de Paiva、 IVAC-Institute of Vaccines and Medical Biologicals、 Queen Saovabha Mem. Inst、 Microgen ... |
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
This report aims to provide a comprehensive presentation of the global market for BCG and Tuberculosis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG and Tuberculosis Vaccine. This report contains market size and forecasts of BCG and Tuberculosis Vaccine in global, including the following market information:
Global BCG and Tuberculosis Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global BCG and Tuberculosis Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five BCG and Tuberculosis Vaccine companies in 2022 (%)
The global BCG and Tuberculosis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of BCG and Tuberculosis Vaccine include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, BioFarma, GreenSignal Bio Pharma, China National Biotec, Biomed Lublin and Taj Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCG and Tuberculosis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global BCG and Tuberculosis Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, by Type, 2022 (%)
Immune Vaccine
Therapy Vaccine
Global BCG and Tuberculosis Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, by Application, 2022 (%)
Self-Procurement
UNICEF
Others
Global BCG and Tuberculosis Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global BCG and Tuberculosis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies BCG and Tuberculosis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies BCG and Tuberculosis Vaccine revenues share in global market, 2022 (%)
Key companies BCG and Tuberculosis Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies BCG and Tuberculosis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC-Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of BCG and Tuberculosis Vaccine, market overview.
Chapter 2: Global BCG and Tuberculosis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of BCG and Tuberculosis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of BCG and Tuberculosis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global BCG and Tuberculosis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のBCG&結核ワクチン市場予測2023-2029：免疫ワクチン、治療ワクチン] (コード：MMG23JU5707)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のBCG&結核ワクチン市場予測2023-2029：免疫ワクチン、治療ワクチン]についてメールでお問い合わせ |
